ductal vs lobular breast cancer

Release time ：Nov-17,2024

Ductal and lobular carcinomas are the two primary subtypes of breast cancer. Generally, ductal carcinoma arises from the ductal system within the breast, whereas lobular carcinoma originates from the lobules. There are notable differences in clinical presentation, treatment approaches, and outcomes between these two subtypes.

Ductal carcinoma is the most prevalent form of breast cancer, constituting approximately 80% of all cases. It often manifests as calcifications on mammograms and is more likely to be detected at an early stage. Conversely, lobular carcinoma is less common, representing 10%-15% of breast cancers, and tends to be more elusive on imaging studies, leading to later-stage diagnosis. In terms of treatment, ductal carcinoma patients may be better suited for breast-conserving surgery combined with radiation therapy, while lobular carcinoma, due to its propensity for multicentricity, may necessitate more extensive surgical resection. Prognostically, although the overall survival rates for ductal and lobular carcinomas are comparable, lobular carcinoma patients may be at a higher risk of recurrence post-surgery.

Early detection and diagnosis are paramount for all types of breast cancer, including ductal and lobular carcinomas. Women are advised to perform regular self-examinations of their breasts and to follow their physician's recommendations for mammograms or other imaging studies. Any detected abnormalities should prompt immediate medical consultation to receive professional assessment and treatment advice. Throughout the treatment process, adherence to medical guidance and active participation in therapy are essential for enhancing treatment efficacy and overall quality of life.